CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 61 filers reported holding CABALETTA BIO INC in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,616,596 | +17.9% | 2,340,118 | 0.0% | 0.78% | +21.7% |
Q2 2023 | $30,210,923 | +686.9% | 2,340,118 | +404.1% | 0.64% | +650.0% |
Q1 2023 | $3,839,364 | -10.6% | 464,252 | 0.0% | 0.09% | -3.4% |
Q4 2022 | $4,294,331 | +1322.0% | 464,252 | 0.0% | 0.09% | +1383.3% |
Q3 2022 | $302,000 | -38.6% | 464,252 | 0.0% | 0.01% | -40.0% |
Q2 2022 | $492,000 | -47.8% | 464,252 | 0.0% | 0.01% | -52.4% |
Q1 2022 | $942,000 | -46.5% | 464,252 | 0.0% | 0.02% | -43.2% |
Q4 2021 | $1,760,000 | -68.8% | 464,252 | 0.0% | 0.04% | -66.4% |
Q3 2021 | $5,645,000 | +41.4% | 464,252 | 0.0% | 0.11% | +54.9% |
Q2 2021 | $3,993,000 | -22.5% | 464,252 | 0.0% | 0.07% | -34.3% |
Q1 2021 | $5,153,000 | -11.1% | 464,252 | 0.0% | 0.11% | -6.1% |
Q4 2020 | $5,794,000 | +15.1% | 464,252 | 0.0% | 0.12% | -6.5% |
Q3 2020 | $5,032,000 | -2.7% | 464,252 | 0.0% | 0.12% | -18.5% |
Q2 2020 | $5,172,000 | -44.8% | 464,252 | -63.9% | 0.15% | -49.3% |
Q1 2020 | $9,375,000 | -58.8% | 1,284,313 | -21.1% | 0.30% | -59.0% |
Q4 2019 | $22,750,000 | – | 1,628,504 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |